JP2010507378A - 細胞培養系、細胞培養系を形成するための方法、および前臨床研究における細胞培養系の使用 - Google Patents
細胞培養系、細胞培養系を形成するための方法、および前臨床研究における細胞培養系の使用 Download PDFInfo
- Publication number
- JP2010507378A JP2010507378A JP2009533730A JP2009533730A JP2010507378A JP 2010507378 A JP2010507378 A JP 2010507378A JP 2009533730 A JP2009533730 A JP 2009533730A JP 2009533730 A JP2009533730 A JP 2009533730A JP 2010507378 A JP2010507378 A JP 2010507378A
- Authority
- JP
- Japan
- Prior art keywords
- cell culture
- cells
- culture system
- cell
- compartment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 123
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000011160 research Methods 0.000 title abstract description 11
- 210000004027 cell Anatomy 0.000 claims abstract description 136
- 239000013543 active substance Substances 0.000 claims abstract description 83
- 210000000601 blood cell Anatomy 0.000 claims abstract description 29
- 238000011218 seed culture Methods 0.000 claims abstract description 29
- 210000002865 immune cell Anatomy 0.000 claims abstract description 28
- 238000000926 separation method Methods 0.000 claims abstract description 25
- 238000012360 testing method Methods 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 15
- 230000003248 secreting effect Effects 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 claims description 32
- 210000004369 blood Anatomy 0.000 claims description 16
- 239000008280 blood Substances 0.000 claims description 16
- 210000002540 macrophage Anatomy 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- 210000001616 monocyte Anatomy 0.000 claims description 15
- 230000001413 cellular effect Effects 0.000 claims description 11
- 238000009640 blood culture Methods 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 8
- 210000001124 body fluid Anatomy 0.000 claims description 7
- 239000010839 body fluid Substances 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 210000002437 synoviocyte Anatomy 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 5
- 230000000242 pagocytic effect Effects 0.000 claims description 5
- 239000012190 activator Substances 0.000 claims description 4
- 208000027866 inflammatory disease Diseases 0.000 claims description 4
- 102000004127 Cytokines Human genes 0.000 claims description 3
- 108090000695 Cytokines Proteins 0.000 claims description 3
- 210000002889 endothelial cell Anatomy 0.000 claims description 3
- 210000002490 intestinal epithelial cell Anatomy 0.000 claims description 3
- 210000000424 bronchial epithelial cell Anatomy 0.000 claims description 2
- 210000001612 chondrocyte Anatomy 0.000 claims description 2
- 210000002919 epithelial cell Anatomy 0.000 claims description 2
- 210000003237 epithelioid cell Anatomy 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 230000001323 posttranslational effect Effects 0.000 claims description 2
- 210000004927 skin cell Anatomy 0.000 claims description 2
- 230000002103 transcriptional effect Effects 0.000 claims description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 claims description 2
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 12
- 238000012512 characterization method Methods 0.000 abstract description 5
- 238000004891 communication Methods 0.000 abstract description 5
- 238000000338 in vitro Methods 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 description 49
- 239000010410 layer Substances 0.000 description 19
- 238000003501 co-culture Methods 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 230000037452 priming Effects 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 230000033077 cellular process Effects 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 102000004889 Interleukin-6 Human genes 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 229920000392 Zymosan Polymers 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 2
- 229960001259 diclofenac Drugs 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000001419 two-dimensional polyacrylamide gel electrophoresis Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000005475 Vascular calcification Diseases 0.000 description 1
- TXEOQHYPZNAJKN-MCDZGGTQSA-N [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate guanidine Chemical compound NC(N)=N.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O TXEOQHYPZNAJKN-MCDZGGTQSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000034720 apoptotic signaling pathway Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- RFCBNSCSPXMEBK-INFSMZHSSA-N c-GMP-AMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=NC=NC(N)=C5N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 RFCBNSCSPXMEBK-INFSMZHSSA-N 0.000 description 1
- 230000009460 calcium influx Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108091005996 glycated proteins Proteins 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 231100000617 superantigen Toxicity 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/34—Internal compartments or partitions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
- C12M25/04—Membranes; Filters in combination with well or multiwell plates, i.e. culture inserts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/5055—Cells of the immune system involving macrophages
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Clinical Laboratory Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006051283A DE102006051283A1 (de) | 2006-10-25 | 2006-10-25 | Zellkultursystem, Verfahren zu seiner Herstellung sowie seine Verwendung in der präklinischen Untersuchung |
| PCT/EP2007/009243 WO2008049607A1 (de) | 2006-10-25 | 2007-10-25 | Zellkultursystem, verfahren zu seiner herstellung sowie seine verwendung in der präklinischen untersuchung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2010507378A true JP2010507378A (ja) | 2010-03-11 |
Family
ID=38973642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009533730A Pending JP2010507378A (ja) | 2006-10-25 | 2007-10-25 | 細胞培養系、細胞培養系を形成するための方法、および前臨床研究における細胞培養系の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090263815A1 (es) |
| EP (2) | EP2084266B1 (es) |
| JP (1) | JP2010507378A (es) |
| CN (1) | CN101541952A (es) |
| CA (1) | CA2667238C (es) |
| DE (1) | DE102006051283A1 (es) |
| DK (1) | DK2084266T3 (es) |
| ES (1) | ES2431052T3 (es) |
| PT (1) | PT2084266E (es) |
| WO (1) | WO2008049607A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104893975B (zh) * | 2015-05-28 | 2016-06-01 | 深圳富利鑫健康产业发展有限公司 | 一种双室选择透过性细胞培养装置及其应用 |
| CN107653201B (zh) * | 2017-08-31 | 2021-03-16 | 浙江美保龙生物技术有限公司 | 一种胞内劳森菌分离方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210021A (en) * | 1991-03-20 | 1993-05-11 | Neuro Probe, Inc. | Multiple-site chemotactic test apparatus and method |
| EP0659766A1 (en) * | 1993-11-23 | 1995-06-28 | Schering-Plough | Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| US20050042751A1 (en) * | 2001-10-31 | 2005-02-24 | Michel Goldman | Generation and use of new types of dendritic cells |
-
2006
- 2006-10-25 DE DE102006051283A patent/DE102006051283A1/de not_active Withdrawn
-
2007
- 2007-10-25 EP EP07819295.2A patent/EP2084266B1/de not_active Not-in-force
- 2007-10-25 PT PT78192952T patent/PT2084266E/pt unknown
- 2007-10-25 DK DK07819295.2T patent/DK2084266T3/da active
- 2007-10-25 CN CNA2007800398159A patent/CN101541952A/zh active Pending
- 2007-10-25 CA CA2667238A patent/CA2667238C/en not_active Expired - Fee Related
- 2007-10-25 ES ES07819295T patent/ES2431052T3/es active Active
- 2007-10-25 WO PCT/EP2007/009243 patent/WO2008049607A1/de active Application Filing
- 2007-10-25 EP EP12186470.6A patent/EP2592139B1/de not_active Not-in-force
- 2007-10-25 JP JP2009533730A patent/JP2010507378A/ja active Pending
-
2009
- 2009-04-22 US US12/428,355 patent/US20090263815A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| JPN6012068318; Ｍｉｃｒｏｂｉｏｌｏｇｙ ａｎｄ Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌ． ４６， Ｎｏ． ３, 2002, ｐｐ． １９５-２０５ * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008049607A1 (de) | 2008-05-02 |
| EP2084266A1 (de) | 2009-08-05 |
| CN101541952A (zh) | 2009-09-23 |
| DK2084266T3 (da) | 2013-10-07 |
| CA2667238A1 (en) | 2008-05-02 |
| EP2592139B1 (de) | 2015-06-24 |
| EP2592139A1 (de) | 2013-05-15 |
| DE102006051283A1 (de) | 2008-04-30 |
| EP2084266B1 (de) | 2013-07-31 |
| ES2431052T3 (es) | 2013-11-22 |
| US20090263815A1 (en) | 2009-10-22 |
| PT2084266E (pt) | 2013-10-09 |
| CA2667238C (en) | 2018-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240329034A1 (en) | Organoids related to immunotherapy and methods of preparing and using the same | |
| Astashkina et al. | A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity | |
| Madara et al. | A simple approach to measurement of electrical parameters of cultured epithelial monolayers: use in assessing neutrophil-epithelial interactions | |
| US8911995B2 (en) | Culture system and method for immunogenicity and immunofunction testing in vitro | |
| EP3548606B1 (en) | In vitro gastrointestinal model comprising lamina propria-derived cells | |
| JP2008022743A (ja) | 新規スフェロイド及びスフェロイドの製造方法、薬剤スクリーニング、毒性評価、病体モデル動物の製造へのスフェロイドの使用、スフェロイド細胞培養キット、抗体のスフェロイド形成のための使用、レクチンのスフェロイド形成のための使用、細胞接着分子のスフェロイド形成のための使用 | |
| CN111593022B (zh) | vMIP-Ⅱ诱导CD8+ T细胞去磷酸化为Tcm及其在药物中的应用 | |
| US20230357722A1 (en) | Methods for identifying modulators of natural killer cell interactions | |
| JP7199427B2 (ja) | 炎症ヒト皮膚のｅｘ ｖｉｖｏモデルおよび抗炎症化合物のスクリーニングのためのその使用 | |
| Raabe et al. | Identification and characterization of a hepatic IL-13–producing ILC3-like population potentially involved in liver fibrosis | |
| JP2010507378A (ja) | 細胞培養系、細胞培養系を形成するための方法、および前臨床研究における細胞培養系の使用 | |
| US20100190155A1 (en) | Methods and kits for measurement of lymphocyte function | |
| KR102511631B1 (ko) | Pbmc 유래 세포독성 t 세포의 신규 용도 | |
| AU2020388676B2 (en) | Antibody producing microfluidic devices | |
| Li et al. | Tissue-engineered 3D cancer microenvironment for screening therapeutics | |
| JP2004305095A (ja) | 細胞活性化検出方法 | |
| Wu et al. | Single polar cell trapping based on the breath figure method | |
| TWI753443B (zh) | 一種用於體外活化免疫細胞之培養基 | |
| WO2024073650A2 (en) | Synovium-on-a-chip | |
| WO2022165586A1 (en) | T cell migration using a human skin-on-chip (soc) model | |
| Garcia | Development of a novel in ovo model for the screening of anti-inflammatory drugs: implications for the cancer therapies | |
| US6551772B1 (en) | Model for viral infection and immune response | |
| CN118647872A (zh) | 细胞迁移、趋化性和功能的高通量测定 | |
| TW202144567A (zh) | 一種體外活化免疫細胞之方法 | |
| Kushibiki et al. | Development of Laser Cell-Chip System for Cell Functional Analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100713 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130611 |